Overall, TERT promoter mutations were detected in 23 out of 72 (31.9%) conjunctiva neoplasia cases, in one out of 53 (1.9%) control tissues and were absent in KS lesions (Table 1). This evidence concerns the gene TERT and Kaposi's sarcoma.